Latest Property News

N1 Holdings reported a sharp rise in first-quarter revenue and customer cash receipts, while expanding its accessible lending capacity to approximately $402 million. The growth came alongside a $5.39 million operating cash outflow and heightened scrutiny of Australia’s private credit sector.

Star Combo Pharma has completed a manufacturing expansion that doubles production capacity, but FY2026 revenue fell 15% and profit before tax dropped to $528,472. The company remains cash-backed and dividend-paying, while its next test is converting spare capacity into stronger OEM and Own Brands growth.

Kiwi Property has closed a NZ$200 million seven-year green bond offer after attracting NZ$395 million of demand from retail and institutional investors. The bonds carry a 1.20% margin and are expected to receive an issue rating of BBB+ from S&P Global Ratings.

Australian Silica Quartz Group has completed a 200-tonne bulk sample at White Swan and is preparing 50 tonnes for shipment to prospective Chinese customers. The customer program is advancing, but ASQ held $912,000 in cash at quarter-end and estimated only 1.7 quarters of funding without proceeds from a Bindoon property sale.

Element 25 has moved its Butcherbird expansion further into delivery, combining early site works with a binding manganese offtake and a potential AU$50 million project finance package. The project still needs financial close, approvals and major construction contracts before the plan becomes an operating mine.

EVT delivered a 17% lift in normalised first-quarter EBITDA to $72.5 million, powered by a sharp recovery in Entertainment and resilient Hotels trading. Thredbo was the drag, while an $800 million property sell-down and ongoing structure review put the group’s Hotels-led strategy under the spotlight.

Zoono Group is seeking up to A$1.61 million from a non-renounceable rights issue after completing a separate A$250,000 placement, with its offer document warning of material uncertainty around going concern. The funds are intended to support shelf-life extension projects, intellectual property and working capital, but investors face dilution and an unresolved legal case.

Lovisa delivered another year of strong reported growth, with revenue rising 17.6% to A$938.8 million as its store network passed 1,100 locations. But comparable store sales grew just 2.0%, leaving management’s expansion engine carrying more of the load while executive incentive hurdles went unmet.

Peet delivered record FY26 earnings as its proposed sale to Ingenia moves through the approval process. Profit rose 77% to $103.4 million, while contracts on hand climbed to $850.7 million and the fully franked dividend increased to 13 cents per share.

Argent BioPharma ended the September quarter with just A$11,000 in cash after A$734,000 of operating outflows, despite retaining A$7.4 million of unused convertible financing capacity. The company is simultaneously expanding its commercial portfolio through NLC antiviral rights and a CannEpil veterinary programme.

RAM Essential Services Property Fund has completed the $218.6 million sale of five retail assets, with proceeds earmarked for debt repayment. The settlement advances REP’s healthcare-focused strategy while leaving refinancing and capital management decisions as the next major tests.

Jatcorp’s revenue rose 23% to $38.9 million in FY2026, but weaker margins, negative operating cash flow and a material going-concern uncertainty leave the nutritional products maker’s recovery unfinished. The company ended the year with $5.6 million in cash after a $4.2 million entitlement offer, while Neurio trademark litigation in China remains unresolved.